Acquired
Novo Nordisk (Ozempic)
Ben Gilbert
You need to make a trade-off somewhere. If you're going to be so narrowly focused on just one or two conditions and really one singular interrelated condition of metabolic disorders, either you can't have all the revenue or you can't be so ludicrously profitable. And turns out the thing that they picked, they can be both.
0
💬
0
Comments
Log in to comment.
There are no comments yet.